All In MedTech

FDA Clearance Tracker · P050051-S005

ARCHITECT AUSAB

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 4, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P050051-S005
Device name
ARCHITECT AUSAB
Applicant location
Abbott Park, IL
Received
Aug 23, 2010
Decided
Apr 4, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P050051

Device type

Device class
Class II
Regulation
21 CFR 866.3172

Every decision under product code LOM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT ABBOTT IRELAND DIAGNOSTICS DIVISION IN SLIGO, IRELAND AND A MANUFACTURING SITE AT ABBOTT DIAGNOSTICS DIVISION, MUREX BIOTECH LIMITED IN KENT, UNITED KINGDOM.

Source documents

Other decisions for Abbott Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.